VANCOUVER, BC / ACCESS Newswire / April 21, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") announces the successful completion of a ...
Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality ...
Discover how medical 3D printing creates patient-specific devices and custom prosthetics. Read our guide to clinical ...
Nektar Therapeutics stock is upgraded from 'Buy' to 'Strong Buy' following robust phase 2b data for REZPEG in atopic ...
Sox9, a master regulator of cartilage formation, switches its target genes dynamically during embryonic limb development ...
A new U.S. government initiative will provide low-cost financing to increase the output of the existing nuclear fleet by 5 GW ...
The number of family care programs in New Hampshire is shrinking. Are complex local and state regulations and business issues ...
University of North Carolina officials worked on options for a new basketball arena. For months, they were prepared to ...
Data highlight RM-055's ability to overcome resistance and provide deep, durable antitumor activity across preclinical models ...
Asheville City Council approved an ordinance update that will give the city an "additional tool" to address abandoned ...
Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients ...
The two will develop XFRA, a distributed network of compute nodes connected to homes with smart panels, batteries and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results